Skip to main content

Parliamentary debates and questions

S5W-13042: Stuart McMillan (Greenock and Inverclyde)

Scottish National Party

Date lodged: 28 November 2017

To ask the Scottish Government what plans the Cabinet Secretary for Health and Sport has to meet the (a) chief medical officer and (b) Secretary of State for Health to discuss the announcement by the National Institute for Care and Excellence (NICE) to stop routine trans-vaginal mesh implants in England, and whether the cabinet secretary also plans to discuss this matter with representatives of NICE.

Answered by: Shona Robison 19 December 2017

NICE undertook a public consultation on revised mesh guidance, and guidance was published on Friday 15 December. NICE IPP guidance applies across the UK, including in Scotland, and the Chief Medical Officer has therefore written to all Health Boards, alerting them to the fact that new guidance will shortly be published, and stressing that it must be implemented. Furthermore, HIS is presently in the process of establishing a Mesh Oversight Group, which will be expected to consider all evidence, adverse events reports, and other material relating to transvaginal mesh, including NICE guidance, and to work with Health Boards to ensure that such material is reflected in pathways of care.

The Chief Medical Officer for Scotland and other Scottish Government officials brief Ministers on transvaginal mesh on an on-going basis. I discussed mesh, including the draft NICE guidance, with the Chief Medical Officer during the week of 27 November.

Both the Chief Medical Officer and I have written to the MHRA to express concerns about the role of the MHRA in relation to transvaginal mesh. Furthermore, given the concerns, I have also written to the Secretary of State for Health, given his overall responsibility for the MHRA asking for a meeting to discuss these concerns.